At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- FinancialsAltman Z-Score 5.75: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.36%
Annual Rate
CNY 0.30Paid annual
Payout Ratio
40.0%Sustainable
Payback Period
73.3 yr
Last Ex-Dividend
Jun 10, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.20BCNY330.26M · vs all stocks (USD)
Trailing P/E
29.33xvs Medical Devices peers
Revenue (TTM)
433.55MCNY64.97M · vs all stocks (USD)
Profit Margin
17.18%vs Medical Devices peers
Beta
0.7280xvs all stocks
52-Week Change
-15.35%vs all stocks
Market Capitalization
2.20BCNY330.26M · vs all stocks (USD)
Enterprise Value
1.58BCNY237.12M · vs all stocks (USD)
Trailing P/E
29.33xvs Medical Devices peers
Price to Sales (TTM)
5.08xvs Medical Devices peers
Price to Book (MRQ)
0.9982xvs Medical Devices peers
Enterprise to Revenue
3.65xvs Medical Devices peers
Enterprise to EBITDA
16.20xvs Medical Devices peers
Gross Margin
46.85%vs Medical Devices peers
Profit Margin
17.18%vs Medical Devices peers
Operating Margin
13.22%vs Medical Devices peers
Return on Assets (TTM)
1.32%vs Medical Devices peers
Return on Equity (TTM)
3.36%vs Medical Devices peers
Revenue (TTM)
433.55MCNY64.97M · vs all stocks (USD)
Revenue per Share (TTM)
4.40CNYUpdated Nov 20, 2026Quarterly Revenue Growth
48.80%vs Medical Devices peers
Gross Profit (TTM)
219.48MCNY32.89M · vs all stocks (USD)
EBITDA (TTM)
70.52MCNY10.57M · vs all stocks (USD)
Net Income (TTM)
74.47MCNY11.16M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
14.89%vs Medical Devices peers
Operating Cash Flow (TTM)
94.94MCNY14.23M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-23.35MCNY-3.50M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.3000CNYUpdated Nov 20, 2026Trailing Annual Dividend Yield
1.36%vs all stocks
Payout Ratio
40.00%vs Medical Devices peers
Minority Interest (Equity)
7.25MCNYFY2025 · Dec 31, 2025Revenue
387.49MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
199.21MCNYFY2025 · Dec 31, 2025Gross Profit
188.28MCNYFY2025 · Dec 31, 2025Operating Income
54.08MCNY8.10M · vs all stocks (USD)
Pre-tax Income
-27.58MCNYFY2025 · Dec 31, 2025Income Tax Expense
12.32MCNYFY2025 · Dec 31, 2025Net Income
-39.90MCNYFY2025 · Dec 31, 2025EBIT
-26.30MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
120.64MCNYFY2025 · Dec 31, 2025Research & Development
20.97MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
37.72MCNYFY2025 · Dec 31, 2025Other Operating Expenses
5.66MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
671.58KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.27MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.3800CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.3800CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
99.84MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
99.84MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-39.90MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
1.96MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-27.72MCNYFY2025 · Dec 31, 2025Free Cash Flow
-73.72MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
78.41MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-39.90MCNYFY2025 · Dec 31, 2025Other Non-cash Items
1.80MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
18.61MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-8.23MCNYFY2025 · Dec 31, 2025Capital Expenditures
-45.99MCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.66BCNYFY2025 · Dec 31, 2025Sale of Investments
2.56BCNYFY2025 · Dec 31, 2025Other Investing Activity
-36.27KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-147.05MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
144.45MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-61.56MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-60.42MCNYFY2025 · Dec 31, 2025Other Financing Charges
1.64MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
24.11MCNYFY2025 · Dec 31, 2025Shares Outstanding
100.17MSharesUpdated Nov 20, 2026Float Shares
57.46MSharesUpdated Nov 20, 2026% Held by Insiders
45.23%vs all stocks
% Held by Institutions
2.76%vs all stocks
Total Cash (MRQ)
1.04BCNY156.59M · vs all stocks (USD)
Total Cash per Share (MRQ)
10.68CNYUpdated Nov 20, 2026Total Debt (MRQ)
433.90MCNY65.02M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1975xvs Medical Devices peers
Current Ratio (MRQ)
3.03xvs Medical Devices peers
Book Value per Share (MRQ)
22.04CNYUpdated Nov 20, 2026Total Assets
2.43BCNY363.99M · vs all stocks (USD)
Total Current Assets
1.48BCNYFY2025 · Dec 31, 2025Total Liabilities
274.04MCNYFY2025 · Dec 31, 2025Total Non-current Assets
945.89MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
15.44MCNYFY2025 · Dec 31, 2025Total Current Liabilities
258.60MCNYFY2025 · Dec 31, 2025Cash
78.41MCNYFY2025 · Dec 31, 2025Cash Equivalents
0.00CNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
78.41MCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.20BCNYFY2025 · Dec 31, 2025Accounts Receivable
79.95MCNYFY2025 · Dec 31, 2025Inventory
114.07MCNYFY2025 · Dec 31, 2025Accounts Payable
102.96MCNYFY2025 · Dec 31, 2025Short-term Debt
116.45MCNYFY2025 · Dec 31, 2025Other Current Liabilities
3.40MCNYFY2025 · Dec 31, 2025Long-term Debt
1.51MCNYFY2025 · Dec 31, 2025Common Stock (Book)
100.17MCNYFY2025 · Dec 31, 2025Retained Earnings
333.47MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.15BCNY322.92M · vs all stocks (USD)
Treasury Stock
29.99MCNYFY2025 · Dec 31, 202552-Week Low
21.60CNYUpdated Nov 20, 202652-Week High
37.08CNYUpdated Nov 20, 202652-Week Change
-15.35%vs all stocks
Beta
0.7280xvs all stocks
50-Day MA
26.59CNYUpdated Nov 20, 2026200-Day MA
28.05CNYUpdated Nov 20, 2026Avg 10-Day Volume
1.51MSharesUpdated Nov 20, 2026Avg 30-Day Volume
1.95MSharesUpdated Nov 20, 2026Diluted EPS (TTM)
0.7500CNYUpdated Nov 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 5.75: safe zoneNotable
Altman Z-Score: 5.75
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Jilin Province Xidian Pharmaceutical Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hainan Huluwa Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tuoxin Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
X4 Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Enwei Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Atea Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Capricor Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Newron Pharmaceuticals SpA
Tier 1ProductionApproval-Gated PipelineRuleRisk
Emergent BioSolutions Inc.
Tier 1ProductionApproval-Gated PipelineRule
Grape King Bio Ltd.
Tier 1ProductionApproval-Gated PipelineRule